TrimRX
US$ 24.20
glp-1 oral New Outperforms Semaglutide FDA Approves Oral Semaglutide as
Description
Injectable GLP-1s must be refrigerated
Why such actions or notices were not rolled out before
No prospective pharmacokinetic interaction studies exist for DOAC-plus-GLP-1-RA combinations
In the SAVOR study DPP-4 inhibition with saxagliptin did not increase or decrease the rate of ischemic events, though the rate of hospitalization for heart failure was increased [27]
1 For patients who do not achieve their target A1C with metformin, the Diabetes Canada 2018 guidelines recommend selecting add-on therapy based on individual patient characteristics
